Best BIIB Cash-Secured Put Strategy — 14-Day Strikes, Up to 1.13% Premium
Biogen Inc. · BIIB · Cash Secured Put · Updated Aug 24, 2026
Biogen Inc. discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally. The company provides TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, and TYSABRI for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; SKYCLARYS to treat Friedreich's Ataxia; QALSODY for treating amyotrophic lateral sclerosis; FUMADERM to treat plaque psoriasis; BENEPALI, an etanercept biosimilar referencing ENBREL; IMRALDI, an adalimumab biosimilar referencing HUMIRA;… Highlighted 14–30 day cash-secured puts on Biogen Inc. (BIIB) reach up to 1.13% annualized yield (1.13% avg on top strikes in the tables below).
View BIIB chartTop Cash Secured Puts (14–30 day)
Open full screener| Strike | Expiration | DTE | Delta | Premium | Yield | Score | Action |
|---|---|---|---|---|---|---|---|
| $205.00 | Sep 11 | 18 | -0.22 | $2.33 | 1.13% | 32 | Open |
Key Metrics
Financial Performance
Cash-secured puts snapshot
Insights
Top pick
Best cash-secured puts for Biogen Inc. (BIIB): $205.00 strike expiring Sep 11, 2026, 1.13% yield.
Short-term opportunities
Biogen Inc. (BIIB) has competitive cash-secured puts expiring within ~14–21 days—use the 14-day screener filter to compare.
Implied volatility
Average IV for Biogen Inc. (BIIB) is 34.1% (elevated)— favorable for premium sellers.
Lowest capital at risk
Lowest strike CSP for Biogen Inc. (BIIB): $205.00 at 1.13% yield.
How to use this page
- Review Biogen Inc. (BIIB) fundamentals — Check stock price, sector, and technicals in the company snapshot, then compare top contract cards.
- Open the screener for Biogen Inc. (BIIB) — Open our Cash Secured Puts screener with BIIB pre-loaded and optional 14-day or 30-day DTE filters.
- Compare and execute — Refine yield, delta, and IV in the screener, then place the trade in your broker.
Analysis
Our analysis of Biogen Inc. (BIIB) cash-secured puts shows average premium yield of 1.13% and peaks at 1.13%. Average implied volatility is 34.1% (peak 34.1%), indicating elevated volatility for premium sellers. Biogen Inc. (BIIB) operates in the Healthcare sector within the Drug Manufacturers - General industry, earning an overall score of 3. Use the tables below to compare strike, DTE, and delta before opening the full screener.
FAQ
What are the best cash-secured puts for Biogen Inc. (BIIB)?
The best cash-secured puts for Biogen Inc. (BIIB) reach up to 1.13% annualized yield (1.13% average on top strikes). This page emphasizes roughly 14–21 day expirations plus 30-day style windows. Compare strike, DTE, delta, and IV in the tables below, then open the screener for full filters.
What are Biogen Inc. (BIIB)'s fundamentals for cash-secured puts?
For Biogen Inc. (BIIB), key fundamentals include last price $216.85, P/E 36.6, market cap $30.7 Billion, Healthcare sector, WSO rating B+, analyst consensus Buy. Fundamentals help you judge assignment risk and premium richness before selling options.
How do I find cash-secured puts for Biogen Inc. (BIIB)?
Use our Cash Secured Puts screener with Biogen Inc. (BIIB) pre-loaded: filter by premium yield, DTE (14-day or 30-day windows), delta, and implied volatility (34.1% avg IV on this page).
What is the average premium yield for Biogen Inc. (BIIB) cash-secured puts?
Average premium yield for Biogen Inc. (BIIB) cash-secured puts is 1.13%, with top contracts up to 1.13%. Yields move with strike, expiration, and IV (avg 34.1%, peak 34.1%).
Is Biogen Inc. (BIIB) a good stock for cash-secured puts?
Biogen Inc. (BIIB) offers cash-secured puts with yields up to 1.13%. WSO rates it B+. It is in Healthcare. IV is elevated—weigh premium income vs. assignment and earnings risk.
What expiration dates are available for Biogen Inc. (BIIB) cash-secured puts?
Biogen Inc. (BIIB) has short-dated contracts (~7–21 DTE) and medium-term expirations (~22–45 DTE) on this page. Use DTE chips to jump to the screener with matching expiration filters.
How does implied volatility affect Biogen Inc. (BIIB) cash-secured puts?
IV drives option premiums: Biogen Inc. (BIIB) averages 34.1% IV (peak 34.1%). Higher IV can mean richer premiums but more price swing—balance yield with delta and DTE.